Products

Microcrystalline Cellulose is purified, partially depolymerized cellulose prepared by treating alpha cellulose obtained as a pulp from fibrous plant material with mineral acids. Several grades of Avicel® PH MCC are available varying in particle size distribution, density and moisture content. Avicel® PH microcrystalline cellulose (MCC) is most often used as a filler, disintegrant, flow aid, and dry binder for tablets and capsules. Avicel® PH-301 has a typical average particle size of 50 µm with a high bulk density of approximately 0.4 g/cc, compared to 0.3 g/cc for most other Avicel® grades. Avicel® PH-301 is primarily used for high shear wet granulation and direct compression. The high bulk density provides increased flowability resulting in improved blending characteristics and tablet uniformity. The high density also helps improve consistency and throughput of the capsule filling process.

Microcrystalline Cellulose is purified, partially depolymerized cellulose prepared by treating alpha cellulose obtained as a pulp from fibrous plant material with mineral acids. Several grades of Avicel® PH MCC are available varying in particle size distribution, density and moisture content. Avicel® PH microcrystalline cellulose (MCC) is most often used as a filler, disintegrant, flow aid, and dry binder for tablets and capsules. Avicel® PH-102 has a typical average particle size of 100 µm and moisture content between 3 and 5%. Avicel® PH-102 is primarily used for direct compression, and dry granulation/roller compaction. The particle size of Avicel® PH-102 provides good flow characteristics. When compressed, Avicel® PH MCC undergoes plastic deformation. The strength of MCC tablets results from hydrogen bonding between the plastically deformed, large surface area cellulose particles. MCC is recognized as the most compactable of any direct compression excipient.

Avicel® SMCC - 50 is used in tablet formulations, employing various manufacturing technologies like direct compression, dry granulation, and wet granulation. It serves multiple functions in pharmaceutical and nutraceutical applications, including acting as a binder, compression aid, filler, and immediate release agent.

Avicel® SMCC HD 90 comprising non-animal origin microcrystalline cellulose, is utilized in various pharmaceutical and nutraceutical applications. Employing direct compression, dry granulation, and wet granulation manufacturing technologies, it serves as a compression aid, filler, and immediate release agent.

Avicel® RC - 591 is versatile, catering to various dosage forms like lotions, sprays, and suspensions. Its manufacturing technology involves direct compression, dry granulation, and wet granulation methods. In pharmaceutical and nutraceutical applications, it serves as a binder, compression aid, immediate release agent, and stabilizer, ensuring product efficacy and stability.

Avicel® PH - 103 is a microcrystalline cellulose used in direct compression, dry granulation, and wet granulation technologies. It serves the healthcare and pharma markets, particularly in oral drug delivery and care solutions. This product is available in granule form.

Avicel® SMCC - 90 composed of microcrystalline cellulose, is utilized in various manufacturing technologies, including direct compression, dry granulation, and wet granulation. It serves as both a filler and an immediate release agent in pharmaceutical and nutraceutical applications.

Avicel® CE-15 a non-animal-derived ingredient, is widely employed in tablet production. It's adaptable to various manufacturing methods like direct compression, dry granulation, and wet granulation. In pharmaceutical and nutraceutical applications, it acts as a binder, compression aid, filler, immediate release agent, and suspension aid. It's supplied in powder form for easy tablet formulation.

Microcrystalline Cellulose is purified, partially depolymerized cellulose prepared by treating alpha cellulose obtained as a pulp from fibrous plant material with mineral acids. Several grades of Avicel® PH MCC are available varying in particle size distribution, density and moisture content. Avicel® PH microcrystalline cellulose (MCC) is most often used as a filler, disintegrant, flow aid, and dry binder for tablets and capsules. Avicel® PH-200 has a typical average particle size of 200 µm and moisture content between 3 and 5%. Avicel® PH-200 is primarily used for direct compression, and dry granulation/roller compaction. Larger particle size of Avicel® PH-200 provides enhanced flow characteristics. When compressed, Avicel® PH MCC undergoes plastic deformation. The strength of MCC tablets results from hydrogen bonding between the plastically deformed, large surface area cellulose particles. MCC is recognized as the most compactable of any direct compression excipient.

Avicel® DG derived from non-animal sources, is a versatile powder used in tablet manufacturing. Its chemical composition includes calcium, hydrogen phosphate, cellulose, and cellulosics. Employing direct compression or wet granulation techniques, it functions as a binder and compression aid in tablet formulations.

Avicel® PH - 112 is used in direct compression, dry granulation, and wet granulation applications. It is caffeine-free, CMR substance-free, diethylene glycol-free, and dioxane-free, ensuring safe and effective pharmaceutical formulations.

Microcrystalline Cellulose is purified, partially depolymerized cellulose prepared by treating alpha cellulose obtained as a pulp from fibrous plant material with mineral acids. Several grades of Avicel® PH MCC are available varying in particle size distribution, density and moisture content. Avicel® PH microcrystalline cellulose (MCC) is most often used as a compression Aid, filler, flow aid, and dry binder for tablets and capsules. Avicel® PH-101 has a typical average particle size of 50 µm and moisture content between 3 and 5%. Avicel® PH-101 is primarily used for wet granulation, extrusion spherization and tablet compression. Avicel® PH MCC rapidly absorbs aqueous binder solution permitting faster addition of fluid as well as shorter wet massing time. At the same time, the water does not become bound water resulting in faster drying time and uniform granular properties.

Avicel® PH - 113 composed of microcrystalline cellulose, finds application in tablet formulations. Manufactured using direct compression, dry granulation, and wet granulation techniques, it serves as a binder and compression aid. Derived from non-animal sources, it meets pharmaceutical and nutraceutical standards.

Avicel® CL - 611 a non-animal-origin ingredient, is used in sprays and suspensions. It's compatible with various manufacturing methods like direct compression, dry granulation, and wet granulation. In pharmaceuticals, it acts as a binder, filler, stabilizer, and immediate release agent. It's also an emulsifying agent and viscosity modifier, aiding suspension.

Avicel® PH - 102SCG is a microcrystalline cellulose used in direct compression, dry granulation, and wet granulation manufacturing technologies. It is essential for producing high-quality pharmaceutical tablets with optimal stability and performance.